Barriers to accessibility of medicines for hyperlipidemia in low- and middle-income countries.
Despite the high burden of hyperlipidemia and the effectiveness of treatment, evidence suggests that the accessibility of hyperlipidemia medicines can be low in many low- and middle-income countries (LMICs). The aim of this study was to identify common barriers to the accessibility of medicines for...
Tallennettuna:
| Päätekijät: | , , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Public Library of Science (PLoS)
2024-01-01
|
| Sarja: | PLOS Global Public Health |
| Linkit: | https://journals.plos.org/globalpublichealth/article/file?id=10.1371/journal.pgph.0002905&type=printable |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|